Marché du microbiome humain – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPBT00002233
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 188
Buy Now

Le marché du microbiome humain devrait atteindre 2 921,68 millions de dollars US d'ici 2028, contre 718,95 millions de dollars US en 2021 ; on estime qu'il croîtra à un TCAC de 22,2 % au cours de la période 2021-2028. Le microbiote humain se compose de milliers de milliards de cellules microbiennes symbiotiques hébergées par chaque personne, principalement des bactéries dans l'intestin. Les microbes, y compris les bactéries, les champignons et les virus, sont l'agent pathogène qui s'accumule au fil du temps, et l'habitat dans l'intestin transforme leurs activités génétiques et leurs processus métaboliques, entraînant une réponse immunitaire anormale contre les substances et les tissus normalement présents dans le corps humain. Plusieurs projets sur le microbiome ont été lancés dans le monde dans le but de comprendre les rôles joués par ces symbiotes et leur impact sur la santé de l'hôte humain. La croissance du marché du microbiome humain est attribuée à des facteurs tels que l'incidence croissante des maladies liées au mode de vie, l'attention croissante portée aux thérapies du microbiome humain et les avancées technologiques croissantes en matière de métagénomique et de séquençage de nouvelle génération. Cependant, les directives gouvernementales strictes et le manque de connaissances sur les examens détaillés entravent la croissance du marché.



Régions lucratives pour le marché du microbiome humain



Aperçu du marché



Incidence croissante des maladies liées au mode de vie



Au cours des dernières décennies, les chercheurs sont venus avec la clarté sur la relation entre le microbiome humain et les maladies liées au mode de vie telles que le cancer, le diabète, l'obésité et la dépression. Les changements dans les modes de vie et les normes sociétales influencent le microbiome à chaque étape de la vie. La modification du microbiome humain peut aider à éliminer ces maladies liées au mode de vie. Selon l'Organisation mondiale de la santé, 13 % de la population mondiale (adultes) était obèse en 2016. Selon le rapport "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation", publié en 2016, les microbes résidant dans le tractus gastro-intestinal humain agissent comme un organe endocrinien dont la composition et la fonctionnalité contribuent au développement de l'obésité. Par conséquent, la transplantation de microbiome fécal/intestinal (GMT), impliquant le transfert de matières fécales d'un donneur sain au patient, est un traitement potentiel de l'obésité.



Le diabète est l'une des urgences sanitaires mondiales du 21e siècle. Selon la Fédération internationale du diabète (FID), le nombre de personnes souffrant de diabète en Amérique du Nord était d'environ 46 millions en 2017, et devrait atteindre 62 millions d'ici 2045, c'est-à-dire avec une prévalence de la maladie d'environ 35 % au cours de la période de prévision. Les niveaux réduits de Firmicutes Clostridia indiquent le microbiome des patients atteints de bactéries productrices de butyrate de diabète et un rapport accru de Bacteroidetes: Firmicutes. Ainsi, le diabète peut être prévenu ainsi que traité en modifiant le microbiome par l'administration de prébiotiques, de probiotiques et de transplantation fécale. Par conséquent, l'incidence croissante des maladies chroniques liées au mode de vie est le moteur de la croissance du marché du microbiome humain.



Informations basées sur les produits



Sur la base des produits, le marché du microbiome humain est segmenté en aliments, aliments médicaux , probiotiques, prébiotiques, médicaments, appareils de diagnostic et suppléments. Le segment des probiotiques devrait détenir la plus grande part de marché en 2021, et le segment des prébiotiques devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Marché du microbiome humain, par produit - 2021 et 2028



Couverture des rapports



Insights basés sur la maladie



Le marché du microbiome humain, par maladie, est segmenté en diabète, cancer, maladies auto-immunes, obésité, troubles mentaux, et d'autres maladies. Le marché du microbiome humain est en train d'émerger en raison de l'incidence croissante de maladies liées au mode de vie telles que le cancer et le diabète. Le segment de l'obésité devrait détenir la plus grande part du marché en 2021, tandis que le segment du diabète devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.



Application-Based Insights



Le marché du microbiome humain, par application, est segmenté en diagnostic et thérapeutique. Le segment thérapeutique devrait détenir une plus grande part de marché en 2021, et on estime en outre qu'il enregistrera un TCAC plus élevé au cours de la période de prévision.



Perspectives stratégiques



Les lancements et approbations de produits sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. Les entreprises du marché du microbiome humain se concentrent sur la stratégie de collaboration pour élargir leur clientèle, ce qui, à son tour, leur permet de conserver leur marque à travers le monde.



Marché du microbiome humain - par produit



< ul>
  • Probiotiques

  • Aliments

  • Prébiotiques

  • Aliments médicaux

  • Appareils de diagnostic

  • Médicaments

  • li>
  • Suppléments


  • Marché du microbiome humain - par maladie




    • Obésité

    • Diabète

    • Auto-immune Troubles

    • Cancer

    • Troubles mentaux

    • Autres


    Marché du microbiome humain - par application




    • Thérapeutique

    • Diagnostic


    Marché du microbiome humain - par géographie




    • Amérique du Nord
      • États-Unis
      • Canada

      • Mexique



    • Europe
      • France

      • Allemagne

      • < li>Italie
      • Royaume-Uni

      • Espagne

      • Reste de l'Europe



    • Asie-Pacifique (APAC) < ul>
    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'Asie-Pacifique



  • Moyen-Orient et Afrique (MEA)
    • Afrique du Sud

    • Arabie saoudite

    • EAU
    • Reste du Moyen-Orient et Afrique



  • Amérique du Sud et centrale (SCAM)
    • Brésil

    • Argentine
    • Reste de l'Amérique du Sud et centrale




  • Profils des entreprises




    • Rebiotix Inc.

    • Yakult Honsha Co., Ltd.

    • Synthetic Biologics Inc.

    • DuPont

    • MaaT Pharma

    • Eligo Bioscience

    • < li>Merck & Co. Inc
    • AOBiome LLC

    • Kaleido

    • Seres Therapeutics


    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the regional analysis in terms of human microbiome market?

    The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.

    What are the driving factors for the human microbiome market across the globe?

    The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.

    What is human microbiome?

    The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.

    The List of Companies - Human Microbiome Market

    1. Rebiotix Inc.
    2. Yakult Honsha Co., Ltd.
    3. Synthetic Biologics Inc.
    4. DuPont
    5. MaaT Pharma
    6. Eligo Bioscience
    7. Merck & Co. Inc
    8. AOBiome LLC
    9. Kaleido
    10. Seres Therapeutics

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports